WellSpring Consumer Healthcare Acquires DerMend and Recticare from Ferndale Pharma Group

January 12, 2026

WellSpring Consumer Healthcare, an Avista Healthcare Partners portfolio company, has acquired the DerMend and Recticare brands from Ferndale Pharma Group. The add-on expands WellSpring’s therapeutic skincare and OTC product portfolio and strengthens its omni-channel retail and e-commerce distribution; financial terms were not disclosed.

Buyers
WellSpring Consumer Healthcare, Avista Healthcare Partners
Targets
DerMend, Recticare
Sellers
Ferndale Pharma Group
Platforms
WellSpring Consumer Healthcare
Location
Michigan, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.